サマリー

血栓症治療薬の世界市場 2022-2026 年
Technavioは血栓症治療薬市場を監視しており、2022-2026年の間に162億4000万ドルの成長が見込まれ、予測期間中にCAGR9.67％で進行しています。当レポートでは、血栓症治療薬市場の全体分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、新規経口抗凝固薬の導入、凝固障害の有病率の増加、心臓治療に対する意識の高まりによって牽引されています。
血栓症治療薬市場の分析には、適応症セグメントと地理的展望が含まれます。
Technavioの血栓症治療薬市場は、以下のようにセグメント化されています。
適応症別
- 肺塞栓症
- DVT
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間における血栓症治療薬市場の成長を促進する主な理由の一つとして、座りがちなライフスタイルが挙げられています。また、血栓症の高い有病率と抗凝固解毒剤の登場は、市場の大きな需要につながると考えられます。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。血栓症治療薬市場に関する当レポートの対象領域は以下の通りです。
- 血栓症治療薬市場のサイジング
- 血栓症治療薬市場の予測
- 血栓症治療薬市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Aspen Pharmacare Holdings Ltd., AuroMedics Pharma LLC, Baxter International Inc, Bayer AG, Biogen Inc), Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co.Ltd.、F. Hoffmann La Roche Ltd.、GoodRx Holdings Inc.、Grifols SA、GlaxoSmithKline Plc、Inari Medical Inc.、Italfarmaco Spa、Johnson and Johnson、Pfizer Inc、Sanofi SA、Vasudha Pharma Chem Ltd. および Viatris Inc.の6社です。また、血栓症治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/thrombosis-drugs-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Indication
o 5.1 Market segments
o Exhibit 24: Chart on Indication - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Indication - Market share 2021-2026 (%)
o 5.2 Comparison by Indication
o Exhibit 26: Chart on Comparison by Indication
o Exhibit 27: Data Table on Comparison by Indication
o 5.3 Pulmonary embolism - Market size and forecast 2021-2026
o Exhibit 28: Chart on Pulmonary embolism - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Pulmonary embolism - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Pulmonary embolism - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Pulmonary embolism - Year-over-year growth 2021-2026 (%)
o 5.4 DVT - Market size and forecast 2021-2026
o Exhibit 32: Chart on DVT - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on DVT - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on DVT - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on DVT - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Indication
o Exhibit 36: Market opportunity by Indication ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 France - Market size and forecast 2021-2026
o Exhibit 62: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.9 Norway - Market size and forecast 2021-2026
o Exhibit 66: Chart on Norway - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Norway - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Norway - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Norway - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Aspen Pharmacare Holdings Ltd.
o Exhibit 85: Aspen Pharmacare Holdings Ltd. - Overview
o Exhibit 86: Aspen Pharmacare Holdings Ltd. - Business segments
o Exhibit 87: Aspen Pharmacare Holdings Ltd. - Key offerings
o Exhibit 88: Aspen Pharmacare Holdings Ltd. - Segment focus
o 10.4 Baxter International Inc.
o Exhibit 89: Baxter International Inc. - Overview
o Exhibit 90: Baxter International Inc. - Business segments
o Exhibit 91: Baxter International Inc. - Key news
o Exhibit 92: Baxter International Inc. - Key offerings
o Exhibit 93: Baxter International Inc. - Segment focus
o 10.5 Boehringer Ingelheim International GmbH
o Exhibit 94: Boehringer Ingelheim International GmbH - Overview
o Exhibit 95: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 96: Boehringer Ingelheim International GmbH - Key news
o Exhibit 97: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 98: Boehringer Ingelheim International GmbH - Segment focus
o 10.6 Bristol Myers Squibb Co.
o Exhibit 99: Bristol Myers Squibb Co. - Overview
o Exhibit 100: Bristol Myers Squibb Co. - Product / Service
o Exhibit 101: Bristol Myers Squibb Co. - Key offerings
o 10.7 Daiichi Sankyo Co. Ltd.
o Exhibit 102: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 103: Daiichi Sankyo Co. Ltd. - Business segments
o Exhibit 104: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 105: Daiichi Sankyo Co. Ltd. - Key offerings
o Exhibit 106: Daiichi Sankyo Co. Ltd. - Segment focus
o 10.8 F. Hoffmann La Roche Ltd.
o Exhibit 107: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 108: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 109: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 110: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 111: F. Hoffmann La Roche Ltd. - Segment focus
o 10.9 GlaxoSmithKline Plc
o Exhibit 112: GlaxoSmithKline Plc - Overview
o Exhibit 113: GlaxoSmithKline Plc - Business segments
o Exhibit 114: GlaxoSmithKline Plc - Key news
o Exhibit 115: GlaxoSmithKline Plc - Key offerings
o Exhibit 116: GlaxoSmithKline Plc - Segment focus
o 10.10 Johnson and Johnson
o Exhibit 117: Johnson and Johnson - Overview
o Exhibit 118: Johnson and Johnson - Business segments
o Exhibit 119: Johnson and Johnson - Key news
o Exhibit 120: Johnson and Johnson - Key offerings
o Exhibit 121: Johnson and Johnson - Segment focus
o 10.11 Pfizer Inc.
o Exhibit 122: Pfizer Inc. - Overview
o Exhibit 123: Pfizer Inc. - Product / Service
o Exhibit 124: Pfizer Inc. - Key news
o Exhibit 125: Pfizer Inc. - Key offerings
o 10.12 Sanofi SA
o Exhibit 126: Sanofi SA - Overview
o Exhibit 127: Sanofi SA - Business segments
o Exhibit 128: Sanofi SA - Key news
o Exhibit 129: Sanofi SA - Key offerings
o Exhibit 130: Sanofi SA - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 131: Inclusions checklist
o Exhibit 132: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 133: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 134: Research methodology
o Exhibit 135: Validation techniques employed for market sizing
o Exhibit 136: Information sources
o 11.5 List of abbreviations
o Exhibit 137: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Indication - Market share 2021-2026 (%)
Exhibits25: Data Table on Indication - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Indication
Exhibits27: Data Table on Comparison by Indication
Exhibits28: Chart on Pulmonary embolism - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Pulmonary embolism - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Pulmonary embolism - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Pulmonary embolism - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on DVT - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on DVT - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on DVT - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on DVT - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Indication ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Norway - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Norway - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Norway - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Norway - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Aspen Pharmacare Holdings Ltd. - Overview
Exhibits86: Aspen Pharmacare Holdings Ltd. - Business segments
Exhibits87: Aspen Pharmacare Holdings Ltd. - Key offerings
Exhibits88: Aspen Pharmacare Holdings Ltd. - Segment focus
Exhibits89: Baxter International Inc. - Overview
Exhibits90: Baxter International Inc. - Business segments
Exhibits91: Baxter International Inc. - Key news
Exhibits92: Baxter International Inc. - Key offerings
Exhibits93: Baxter International Inc. - Segment focus
Exhibits94: Boehringer Ingelheim International GmbH - Overview
Exhibits95: Boehringer Ingelheim International GmbH - Business segments
Exhibits96: Boehringer Ingelheim International GmbH - Key news
Exhibits97: Boehringer Ingelheim International GmbH - Key offerings
Exhibits98: Boehringer Ingelheim International GmbH - Segment focus
Exhibits99: Bristol Myers Squibb Co. - Overview
Exhibits100: Bristol Myers Squibb Co. - Product / Service
Exhibits101: Bristol Myers Squibb Co. - Key offerings
Exhibits102: Daiichi Sankyo Co. Ltd. - Overview
Exhibits103: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits104: Daiichi Sankyo Co. Ltd. - Key news
Exhibits105: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits106: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits107: F. Hoffmann La Roche Ltd. - Overview
Exhibits108: F. Hoffmann La Roche Ltd. - Business segments
Exhibits109: F. Hoffmann La Roche Ltd. - Key news
Exhibits110: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits111: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits112: GlaxoSmithKline Plc - Overview
Exhibits113: GlaxoSmithKline Plc - Business segments
Exhibits114: GlaxoSmithKline Plc - Key news
Exhibits115: GlaxoSmithKline Plc - Key offerings
Exhibits116: GlaxoSmithKline Plc - Segment focus
Exhibits117: Johnson and Johnson - Overview
Exhibits118: Johnson and Johnson - Business segments
Exhibits119: Johnson and Johnson - Key news
Exhibits120: Johnson and Johnson - Key offerings
Exhibits121: Johnson and Johnson - Segment focus
Exhibits122: Pfizer Inc. - Overview
Exhibits123: Pfizer Inc. - Product / Service
Exhibits124: Pfizer Inc. - Key news
Exhibits125: Pfizer Inc. - Key offerings
Exhibits126: Sanofi SA - Overview
Exhibits127: Sanofi SA - Business segments
Exhibits128: Sanofi SA - Key news
Exhibits129: Sanofi SA - Key offerings
Exhibits130: Sanofi SA - Segment focus
Exhibits131: Inclusions checklist
Exhibits132: Exclusions checklist
Exhibits133: Currency conversion rates for US$
Exhibits134: Research methodology
Exhibits135: Validation techniques employed for market sizing
Exhibits136: Information sources
Exhibits137: List of abbreviations